证券代码：688247 证券简称：宣泰医药 公告编号：2025-035 上海宣泰医药科技股份有限公司 关于参加 2025 年半年度科创板生物制品及 CXO 行业集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议召开时间：2025 年 9 月 15 日(星期一) 下午 15:00-17:00 （一） 会议召开时间：2025 年 9 月 15 日（星期一） 下午 15:00-17:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 9 月 8 日（星期一）至 9 月 12 日（星期五）16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过上海宣泰医药科技股 份有限公司（以下简称"公司"）邮箱 info@sinotph.com 进行提问。公司将在说明 会上对投资者普遍关注的问题进行回答。 公司已于 2025 ...

Market Overview - The main funds in the Shanghai and Shenzhen markets experienced a net outflow of 71.426 billion yuan, with the Sci-Tech Innovation Board seeing a net outflow of 6.808 billion yuan [1] - A total of 191 stocks saw net inflows, while 395 stocks experienced net outflows [1] Sci-Tech Innovation Board Performance - On the Sci-Tech Innovation Board, 146 stocks rose, with one stock, Haibo Sichuang, hitting the daily limit, while 440 stocks declined [1] - The top three stocks with the highest net inflows were: - Yuanjie Technology with a net inflow of 292.44 million yuan - Sainuo Medical with a net inflow of 204.62 million yuan - Aters with a net inflow of 147.56 million yuan [1][2] Continuous Fund Flow - There are 29 stocks that have seen continuous net inflows for more than three trading days, with Hanwujing leading at 11 consecutive days of inflow [2] - Conversely, 200 stocks have experienced continuous net outflows, with Xuantai Pharmaceutical leading at 17 consecutive days of outflow [2] Top Net Inflow Stocks - The top stocks by net inflow include: - Yuanjie Technology: 292.44 million yuan, 10.50% inflow rate, 13.01% increase - Sainuo Medical: 204.62 million yuan, 7.96% inflow rate, 12.67% increase - Aters: 147.56 million yuan, 13.72% inflow rate, 3.34% increase [2][3] Top Net Outflow Stocks - The stocks with the highest net outflows include: - Haiguang Information: 805 million yuan outflow, 3.42% decrease - Lanqi Technology: 750 million yuan outflow - Dongxin Co.: 474 million yuan outflow [1][2] Summary of Fund Flow Trends - The overall trend indicates a significant outflow of funds from the market, particularly in the Sci-Tech Innovation Board, with a notable number of stocks experiencing prolonged periods of net outflows [1][2]

Group 1 - The core viewpoint of the news is that Xuantai Pharmaceutical has shown significant trading activity and financial performance, with a notable increase in financing and a slight decrease in net profit year-on-year [1][2]. - On September 1, Xuantai Pharmaceutical's stock rose by 1.74%, with a trading volume of 64.42 million yuan. The financing buy-in amount for the day was 9.68 million yuan, while the net financing purchase was 6.27 million yuan [1]. - As of September 1, the total balance of margin trading for Xuantai Pharmaceutical was 88.76 million yuan, accounting for 1.67% of its market capitalization, indicating a high level of financing activity compared to the past year [1]. Group 2 - As of June 30, the number of shareholders for Xuantai Pharmaceutical was 8,020, a decrease of 4.40% from the previous period, while the average circulating shares per person increased by 4.60% to 17,745 shares [2]. - For the first half of 2025, Xuantai Pharmaceutical reported a revenue of 220 million yuan, a year-on-year increase of 0.74%, but the net profit attributable to shareholders decreased by 15.82% to 45.59 million yuan [2]. - Since its A-share listing, Xuantai Pharmaceutical has distributed a total of 74.36 million yuan in dividends [3].

Market Overview - The main funds in the Shanghai and Shenzhen markets experienced a net outflow of 69.47 billion yuan, with the Sci-Tech Innovation Board seeing a net outflow of 3.65 billion yuan [1] - A total of 251 stocks saw net inflows, while 333 stocks experienced net outflows [1] Sci-Tech Innovation Board Performance - On the Sci-Tech Innovation Board, 215 stocks rose, with one stock, Hangke Technology, hitting the daily limit, while 367 stocks fell [1] - The top three stocks with the highest net inflows were Yuntian Lifa (23.77 million yuan), Baijie Shenzhou (23.09 million yuan), and Daqian Energy (20.33 million yuan) [1] Continuous Fund Flow Analysis - There were 52 stocks with continuous net inflows for more than three trading days, with KHHW leading at nine consecutive days of inflow [1] - Conversely, 155 stocks had continuous net outflows, with ST Nuotai and Xuantai Pharmaceutical both experiencing 14 consecutive days of outflow [1] Top Fund Inflows - The top stocks by net inflow included: - Yuntian Lifa: 23.77 million yuan, 6.20% inflow rate, 6.38% increase [1] - Baijie Shenzhou: 23.09 million yuan, 9.56% inflow rate, 12.55% increase [1] - Daqian Energy: 20.33 million yuan, 16.32% inflow rate, 7.12% increase [1] Notable Outflows - The stock with the highest net outflow was SMIC, with a net outflow of 1.92 billion yuan and a 3.74% decrease [1] - Other significant outflows included Haiguang Information (864 million yuan) and Shijia Photon (382 million yuan) [1]

Core Points - Xuantai Pharmaceutical's stock price as of August 25, 2025, is 12.16 yuan, down 0.05 yuan or 0.41% from the previous trading day [1] - The company is engaged in the research, production, and sales of high-end generic drugs and innovative drugs, primarily in the fields of anti-infection and anti-tumor [1] - On August 25, 2025, a total of 311 million shares were unlocked, accounting for 68.61% of the total share capital, with an unlock market value of approximately 3.798 billion yuan [1] Financial Performance - The opening price on August 25 was 12.18 yuan, with a high of 12.42 yuan and a low of 11.99 yuan [1] - The trading volume for the day was 81,100 hands, with a total transaction amount of 99 million yuan [1] - On the same day, there was a net outflow of 5.1046 million yuan in main funds, representing 0.09% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow of main funds reached 27.6088 million yuan, accounting for 0.5% of the circulating market value [1]

Summary of Key Points Core Viewpoint - On August 25, a total of 6 listed companies experienced the lifting of restrictions on their shares, with a total market value of approximately 3.883 billion yuan being unlocked [1]. Group 1: Companies and Share Unlocking Details - Zhongke Jincai (Stock Code: 002657) had 1.2562 million shares released from equity incentive restrictions [1]. - Oupokangshi (Stock Code: 300595) had 525,300 shares released from equity incentive restrictions [1]. - United Chemical (Stock Code: 301209) had 55.5 million shares released from pre-issue restrictions [1]. - Xuantai Pharmaceutical (Stock Code: 688247) had 31.1 million shares released [1]. - Diaowe (Stock Code: 688381) had 800,000 shares released [1]. - Tailin Micro (Stock Code: 688591) had 240,000 shares released [1].

Core Viewpoint - On August 25, a total of 12 companies had their restricted shares unlocked, with a combined unlocking volume of 770 million shares, amounting to a market value of 14.786 billion yuan based on the latest closing prices [1] Summary by Category Unlocking Volume - Six companies had an unlocking volume exceeding 10 million shares, with Xuantai Pharmaceutical, Rongbai Technology, and Yaxing Chemical leading at 311 million shares, 250 million shares, and 72.1154 million shares respectively [1] Unlocking Market Value - Six companies had an unlocking market value exceeding 100 million yuan, with Rongbai Technology, Xuantai Pharmaceutical, and United Chemical leading at 5.707 billion yuan, 3.798 billion yuan, and 1.841 billion yuan respectively [1] Proportion of Total Share Capital - Five companies had an unlocking proportion exceeding 10% of their total share capital, with Xuantai Pharmaceutical, Rongbai Technology, and Kaige Precision Machinery leading at 68.61%, 34.91%, and 23.36% respectively [1]

Summary of Key Points Core Viewpoint - A total of 37 stocks in the A-share market will face a lock-up expiration next week, with a combined unlock quantity of 5.068 billion shares, amounting to a market value of 92.468 billion yuan, reflecting a week-on-week increase of 1.74% [1]. Unlocking Stock Details - The stocks with the highest unlock market value are Xugong Machinery and Dazhu CNC, each exceeding 31 billion yuan. The unlocking market values for these stocks are 31.908 billion yuan and 31.647 billion yuan, respectively [2][3]. - Xugong Machinery will unlock 3.569 billion shares on August 29, all from a private placement to institutional investors. Dazhu CNC will unlock 359 million shares on August 28, all from original shareholders' lock-up [2][3]. - The market performance of these stocks shows that Xugong Machinery, Dazhu CNC, and Rongbai Technology have increased by 6.68%, 13.72%, and 2.51% respectively since August [2]. Detailed Unlocking Information - The detailed unlocking information for Xugong Machinery indicates that the largest shareholders include Xuzhou Engineering Machinery Group Co., Ltd. and others, with shares coming from a private placement completed in August 2022 at an issue price of 5.55 yuan per share [3][4]. - As of August 22, Xugong Machinery's stock price is 8.94 yuan per share, with a market capitalization of 105.1 billion yuan. The unlocking shareholders have an unrealized gain of over 80%, totaling more than 14 billion yuan [4]. Significant Changes in Circulation - Among the 37 stocks facing unlocking, five stocks will see their circulation increase by over 100%, including Dazhu CNC, Xuantai Pharmaceutical, Hongying Intelligent, Chengdian Guangxin, and Zhenhua Wind Power, with unlocking ratios of 84.39%, 68.61%, 65.47%, 47.30%, and 43.04% respectively [10]. - The circulation of these stocks will increase significantly, with Dazhu CNC's circulation increasing by 576.53% [10].

Core Insights - Xuantai Pharmaceutical (688247) reported a slight increase in revenue but a significant decline in net profit for the first half of 2025, indicating challenges in profitability despite stable sales growth [1] Financial Performance - Total revenue for the first half of 2025 reached 220 million yuan, a year-on-year increase of 0.74% [1] - Net profit attributable to shareholders was 45.59 million yuan, down 15.82% compared to the previous year [1] - Gross margin decreased to 41.23%, a decline of 15.76% year-on-year [1] - Net margin also fell to 20.76%, down 16.44% from the previous year [1] - Operating expenses increased by 18.16%, totaling 21.60 million yuan, which accounted for 9.84% of revenue [1] Cash Flow and Assets - Operating cash flow per share decreased by 24.1% to 0.11 yuan [1] - Cash and cash equivalents dropped by 21.71% to 209 million yuan [2] - Accounts receivable increased by 15.24% to 82.12 million yuan, indicating potential cash collection issues [1][2] Liabilities and Expenses - Interest-bearing liabilities decreased by 29.72% to 38,200 yuan [1] - Employee compensation liabilities fell by 63.89% due to the payment of last year's bonuses [6] - Financial expenses rose by 62.43%, attributed to decreased interest income from bank deposits and currency fluctuations [6] Investment and Capital Expenditure - The company’s capital expenditures are crucial for its performance, and the effectiveness of these investments should be closely monitored [7] - The return on invested capital (ROIC) for the previous year was 9.94%, indicating average capital returns [7]

Group 1 - The core point of the article is that 31 stocks will have their restrictions lifted next week, with a total market value of 23.481 billion yuan based on the latest closing prices [1] - Rongbai Technology has the highest market value of restricted shares to be released, with 250 million restricted shares becoming tradable next week, primarily consisting of original shareholders' restricted shares from the initial public offering [1] - Several companies, including Nine Company-WD, Baiwei Storage, Rongbai Technology, Wanma Co., and Yinhui Technology, have recently received institutional research [1] Group 2 - The table lists the stocks with the highest market value of restrictions lifted, including Rongzi Technology (5.707 billion yuan), Zhenhua Wind Power (5.282 billion yuan), and Xuantai Pharmaceutical (3.798 billion yuan) [3] - The percentage of restricted shares released relative to the total shares varies, with Xuantai Pharmaceutical having 68.61% of its shares restricted, while Zhenhua Wind Power has 43.04% [3] - The price changes since August for these stocks show varied performance, with Kai Ge Precision Machinery increasing by 31.54% and Xuantai Pharmaceutical decreasing by 4.01% [3]